ArticlePharmacotherapy2024

Pilot and feasibility study of dietary composition with elexacaftor-tezacaftor-ivacaftor concentrations in people with cystic fibrosis.

Natalie R Rose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.